Redeye raises its Base Case and EBIT forecasts following a Q3 with better-than-expected margins. Fortnox is continuously expanding its offering, which we expect to drive future ARPC growth together with increased usage of its current offering.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/